Research demonstrates 13% relative reduction in prostate cancer deaths but highlights overdiagnosis concerns, prompting calls for risk-based screening approaches.
Read More
Self-collection for HPV and other infections offers a more convenient, private way to complete recommended screenings—helping reach women who might otherwise delay or skip care.
Read More
PATHFINDER 2 study results indicate more than half of cancers detected by Galleri test were found in early stages, with three-quarters having no current screening options.
Read More
A study of over 10 million men reveals frequent testing of patients unlikely to benefit, raising questions about current screening practices.
Read More
Partnership will bring Galleri multi-cancer early detection test to South Korea, with potential expansion to Japan and Singapore.
Read More